Diphtheria Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Tagraxofusp-erzs, an IL-3 Diphtheria Fusion Protein, in Combination With Gemtuzumab Ozogamicin in Patients With Relapsed/Refractory AML
Condition:   Acute Myeloid Leukemia Interventions:   Drug: Dose Escalation -tagraxofusp-erzs;   Drug: Dose Expansion at RP2D -tagraxofusp-erzs Sponsors:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;   StemlineTherapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2023 Category: Research Source Type: clinical trials

Vibration and Shotblocker Use in Pregnant Women While Giving Tetanus + Diphtheria Vaccine
Condition:   Pain Interventions:   Other: Local mechanical vibration;   Other: Shotblocker group Sponsor:   Hasan Kalyoncu University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2023 Category: Research Source Type: clinical trials